Exhibit 99.1 Nuvectis Pharma, Inc. Reports Third Quarter 2025 Financial Results and Business Highlights November 4, 2025, Fort Lee, NJ - Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today reported its financial results for the third quarter 2025 and provided an update on recent business progress. Ron Bentsur, ...